Skip to main content

Retractable Technologies, Inc.

corporate_fare Company Profile

Retractable Technologies, Inc.

RVP·NYSE·Industrial Applications And Services·CIK 0000946563

Retractable Technologies, Inc. manufactures and markets safety medical products, predominantly syringes, for the healthcare industry. The company was incorporated in Texas in 1994. Its syringes are described as well-suited for administering vaccinations. Retractable Technologies operates manufacturing facilities in Little Elm, Texas, and also uses manufacturers in China. The source also describes trade measures affecting the company's imports from China. On September 13, 2024, the Office of the U.S. Trade Representative revealed final adjustments to increase tariffs on certain goods imported from China under Section 301 of the Trade Act of 1974, including syringes and needles at a rate of 100%. Beginning in early 2025 and throughout much of the year, additional widespread tariffs were imposed on most products imported into the U.S. under the International Emergency Economic Powers Act (IEEPA), in addition to the Section 301 tariffs then in effect. Throughout 2025, prevailing tariff rates on various products and certain countries of origin, including many of the company's products, fluctuated greatly, which the company states negatively impacted its ability to predict import costs and negatively impacted its business. In February 2026, the U.S. Supreme Court ruled that the President's use of IEEPA to impose reciprocal tariffs exceeded his authority and that the IEEPA tariffs must be vacated. The 2024 Section 301 tariff of 100% on syringes and needles from China remains unchanged. Effective February 20, 2026, a 10% ad valorem duty went into effect under Section 122 of the Trade Act, in addition to the Section 301 tariffs. As of March 9, 2026, the prevailing tariff rate on most syringe and needle products imported from China was 120%; other products imported from China that are not needles and syringes are subject to a 20% tariff rate.

Retractable Technologies, Inc. (NYSE:RVP) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 1 item for RVP at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Recent SEC coverage for RVP spans 10-Q.

Recent high-impact activity:

  • Retractable Q3 Sales Jump 40% but Gross Profit Collapses to $193K; Controls Still Not Effective

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$38.27M
Net Income
-$12.57M
Diluted EPS
-$0.43
Op. Cash Flow
-$7.06M
Gross Profit
$47.05K
Operating Income
-$21.18M
Cash & Equivalents
$2.59M
Debt / Equity
0.00×
Net Margin
-32.8%
Shares Outstanding
29.94M sh
Source: 10-K · filed 2026-03-27 · accession 0001104659-26-036053

Short Interest & Short Volume

1.13 days to cover

FINRA reported short interest of 22,900 shares in RVP as of the October 30, 2026 settlement, a 15.8% decrease from the prior period — about 1.1 days to cover at its recent average daily volume. On November 20, 2026, 50.4% of RVP volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)22,900 shares as of October 30, 2026
Change vs prior period▼ 15.8%
Days to cover1.13 at avg daily volume of 20,198
Daily short volume (FINRA facilities)50.4% of 18,600 shares on November 20, 2026
5-day average short volume47.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

$0.62
52-week range · as of 2026-11-16 $0.53 – $0.87
Market cap
$16.7M
Volume
47.3K (1.3× avg)
3-mo avg 35.1K
Live data · 2026-11-21 16:14 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RVP - Latest Insights

RVP
Nov 16, 2026, 1:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.552
Real-time Price: $0.620 info
Change: +$0.068 (+12%) info
Market Cap: $16.705M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets